Pain Intensity in Sickle Cell Disease
14 nov. 2022 10h00 HE
|
Experimental Biology and Medicine
WASHINGTON, Nov. 14, 2022 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 247, Issue 17, September, 2022) improves our understanding of pain phenotypes...
Genomic transposable elements modify the progression of Parkinson's disease
08 nov. 2022 10h00 HE
|
Experimental Biology and Medicine
WASHINGTON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 247, Issue 18, September, 2022) improves our understanding of genomic...
Significant MindMed Investor Demands Federal Investigation to Probe Serious Allegations of Misconduct
03 nov. 2022 08h08 HE
|
Concerned Shareholders of Company MindMed
SHERIDAN, Wyo., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Today, FCM MM HOLDINGS, LLC (“FCM”) notifies shareholders that it has formally filed a complaint (the “Complaint”) with the Securities and Exchange...
Rapid Micro Biosystems to Announce Third Quarter 2022 Financial Results on November 10, 2022
02 nov. 2022 08h00 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Launch of the Merkin Prize in Biomedical Technology
31 oct. 2022 13h00 HE
|
Broad Institute of MIT and Harvard
CAMBRIDGE, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Nominations are now open for the first award of the Richard N. Merkin Prize in Biomedical Technology, which recognizes novel technologies that...
Panoramic Health Launches Clinical Research Division to Drive Discovery of Novel Kidney Disease Therapies
26 oct. 2022 08h00 HE
|
Panoramic Health
TEMPE, Ariz., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Today, Panoramic Health℠, the nation's leading integrated value-based kidney care platform, announced the launch of its clinical research division...
Deepfake Technology in Drug Design
20 oct. 2022 12h00 HE
|
InSilico Medicine
New York, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage artificial intelligence (AI)-driven drug discovery company, is utilizing the same deepfake technology used to create...
Rapid Micro Biosystems to Exhibit at the 2022 PDA Pharmaceutical Microbiology Conference
04 oct. 2022 08h30 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Lower Price on Eliquis for DVT Prevention at Canada Drugs Direct
19 sept. 2022 19h00 HE
|
Canada Drugs Direct
VICTORIA, British Columbia, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Major health risks stemming from blood clots moving through arteries and into the heart, lungs, brain or other organs of the body are...
Rapid Micro Biosystems CEO Rob Spignesi to Speak at the 2022 PDA/FDA Joint Regulatory Conference
12 sept. 2022 09h00 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...